The reactome enrichment scatter plot (Figure 4E) highlighted pathways, such as constitutive signaling by aberrant PI3K in cancer and PI3K/AKT signaling in cancer, which are relevant to Esc’s anti-CRC effects. This evidence concerns the gene AKT1 and colorectal carcinoma.